Association between historically high frequencies of neural tube defects and the human T homologue of mouse T (Brachyury)

American Journal of Medical Genetics

Volumn 92, Issue 3, 2000, Pages 206-211

  Shields, Denis C ^a   Ramsbottom, Dorothy ^b,g   Donoghue, Cait ^b   Pinjon, Emmanuelle ^b   Kirke, Peadar N ^c   Molloy, Anne M ^b   Edwards, Yvonne H ^d   Mills, James L ^e   Mynett Johnson, Lesley ^b   Weir, Donald G ^b   Scott, John M ^b   Whitehead, Alexander S ^f  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c HEALTH RESEARCH BOARD   (Ireland)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g Forensic Science Laboratory Dulin Ireland   (Ireland)

Author keywords

Folate; Genetics; MTHFR; Spina bifida

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; NEURAL TUBE DEFECT; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SPINA BIFIDA;

ADOLESCENT; ADULT; ALLELES; ANIMALS; DNA MUTATIONAL ANALYSIS; FEMALE; FETAL PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICE; NEURAL TUBE DEFECTS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; RISK; T-BOX DOMAIN PROTEINS;

EID: 0034729227     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000529)92:3<206::AID-AJMG9>3.0.CO;2-W     Document Type: Article

References (32)

1. Casey ES, O'Reilly MA, Conlon FL, Smith JC. 1998. The T-box transcription factor Brachyury regulates expression of eFGF through binding to a non-palindromic response element. Development 125:3887-3894.
2. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptual vitamin supplementation. N Engl J Med 327: 1832-1835.
3. Fleming A, Copp AJ. 1998. Embryonic folate metabolism and mouse neural tube defects. Science 280:2107-2109.
4. Harmon DL, Woodside JV, Yarnell JWG, McMaster D, Young IS, McCrum EE, Gey KF, Whitehead AS, Evans A. 1996. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Q J Med 89:571-577.
5. Harris MJ, Juriloff DM. 1997. Genetic landmarks for defects in mouse neural tube closure. Teratology 56:177-187.
6. Herrman BG, Kispert A. 1994. The T gene in embryogenesis. Trends Genet 10:280-286.
7. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9.
8. Johnson Z, McDonnell B, Delany V, Dack P. 1998. The epidemiology of neural tube defects in the east of Ireland 1980-1994. Teratology 57:38 [abstract].
9. Kirke PN, Mills JL, Whitehead AS, Molloy A, Scott JM. 1996. Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 348:1037-1038.
10. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86:703-708.
11. Little J. 1992. Risks in siblings and other relatives. In: Elwood JM, Little J, Elwood JH, editors. Epidemiology and control of neural tube defects. Oxford, UK: Oxford University Press. p 604-676.
12. Little J, Nevin W. 1992. Genetic models. In: Elwood JM, Little J, Elwood JH, editors. Epidemiology and control of neural tube defects. Oxford, UK: Oxford University Press. p 677-710.
13. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
14. Molloy AM, DalyS, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM. 1997. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349: 1591-1593.
15. Molloy AM, Mills JL, Kirke PN, Ramsbottom D, McPartlin JM, Burke H, Conley M, Whitehead AS, Weir DG, Scott JM. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet 78:155-159.
16. Morrison K, Papapetrou C, Attwood J, Hol F, Lynch SA, Sampath A, Hamel B, Burn J, Sowden J, Stott D, et al. 1996. Genetic mapping of the human homologue (T ) of mouse T (Brachyury ) and a search for allele association between human T and spina bifida. Hum Mol Genet 5:669-674.
17. Morrison K, Papapetrou C, Hol FA, Mariman ECM, Lynch SA, Burn J, Edwards YH. 1998. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62:379-396.
18. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338:131-137.
19. Murphy M, Seagroatt V, Hey K, O'Donnell M, Godden, M, Jones N, Botting B. 1996. Neural tube defects 1974-1994: down but not out. Arch Dis Child Fetal Neonatal Ed 75:F133-134.
20. Papapetrou C, Edwards YH, Sowden JC. 1997. The T transcription factor functions as a dimer and exhibits a common polymorphism Gly-177-Asp in the conserved DNA-binding domain. FEBS Lett 409:201-206.
21. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
22. Schaid DJ, Sommer SS. 1994. Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet 55:402-409.
23. Shields DC, Kirke P, Mills JL, Ramsbottom D, Molloy AM, Burke H, Weir DG, Scott JM, Whitehead AS. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055.
24. Smith JL, Schoenwolf GC. 1997. Neurulation: coming to closure. Trends Neurosci 20:510-517.
25. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-511.
26. Statacorp. 1997. Stata statistical software: release 5.0. College Station, TX: Stata Corp.
27. Tada M, Casey ES, Fairclough L, Smith JC. 1998. Bixl, a direct target of Xenopus T-box genes, causes formation of ventral mesoderm and endoderm. Development 125:3997-4006.
28. Trembath D, Sherbondy AL, Vandyke DC, Shaw GM, Todoroff K, Lammer EJ, Finnell RH, Marker S, Lerner G, Murray JC. 1999. Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population. Teratology 59:331-341.
29. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62:969-978.
30. Whitehead AS, Gallagher PM, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. 1995. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q J Med 88:763-766.
31. Wilson V, Rashbass P, Beddington RSP. 1993. Chimeric analysis of T (Brachyury) gene function. Development 117:1321-1331.
32. Zhao Q, Behringer RR, de Crumbrugge B. 1996. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene. Nat Genet 13:275-283.